Inspire Medical Systems, Inc. balance sheet INSP

Annual Quarterly

As of Sep 30, 2026, Inspire Medical Systems, Inc. had total assets of $953.0 million and total liabilities of $126.1 million. Total assets were up 18.0% from a year earlier. Stockholders' equity was $826.9 million. It held $453.1 million in cash and investments against $28.6 million of total debt, net cash of $424.5 million. The current ratio, current assets divided by current liabilities, was 6.45.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
Assets
Cash
191
+69.1%
105
-30.2%
150
-19.1%
186
-58.0%
442
+105.9%
214
+12.6%
191
+733.4%
23
Short-term investments
137
-34.6%
203
-31.1%
295
+7.5%
275
+2698.5%
10
0
-100.0%
44
-65.4%
127
Long-term investments
125
+41.6%
96
+35.7%
71
+676.5%
9
0
-100.0%
10
0
-100.0%
6
Cash and investments
453
+10.3%
405
-21.7%
517
+10.0%
470
+4.0%
451
+101.2%
224
-4.2%
234
+50.5%
156
Receivables
105
-3.0%
120
+28.6%
93
+3.5%
90
+46.8%
61
+79.1%
34
+36.4%
25
+90.9%
13
Inventory
179
+26.2%
145
+81.3%
80
+136.4%
34
+185.1%
12
-31.0%
17
+103.2%
8
+45.3%
6
Total current assets
628
+7.0%
584
-7.5%
631
+6.2%
594
+12.0%
530
+97.4%
269
-0.5%
270
+58.2%
171
Property and equipment, net
86
-6.4%
98
+36.1%
72
+79.9%
40
+131.8%
17
+103.3%
8
+59.8%
5
+74.4%
3
Total assets
953
+18.0%
907
+12.2%
808
+19.4%
677
+19.8%
565
+91.4%
295
+4.9%
281
+55.1%
181
Liabilities and equity
Total current liabilities
97
-12.2%
96
+8.5%
89
+13.3%
78
+27.7%
61
+48.1%
41
+99.3%
21
+23.0%
17
Total liabilities
126
-10.7%
126
+6.3%
119
+13.8%
104
+51.4%
69
+4.3%
66
+28.4%
51
+24.2%
41
Stockholders' equity
827
+24.1%
781
+13.3%
690
+20.5%
573
+15.4%
496
+116.6%
229
-0.3%
230
+64.3%
140
Debt
Long-term debt
—
—
—
—
—
24
+0.0%
24
+0.0%
24
Lease liabilities
29
-12.2%
32
+1.1%
32
+28.0%
25
+180.0%
9
-2.6%
9
+54.7%
6
+610.9%
1
Total debt
29
-12.2%
32
+1.1%
32
+28.0%
25
+180.0%
9
-73.6%
34
+10.6%
30
+20.0%
25
Net cash
424
+12.2%
372
-23.2%
485
+9.0%
445
+0.5%
443
+131.9%
191
-6.5%
204
+56.4%
130
Ratios
Current ratio
6.45x
6.08x
7.13x
7.60x
8.66x
6.50x
13.02x
10.12x
Debt to equity
0.03x
0.04x
0.05x
0.04x
0.02x
0.15x
0.13x
0.18x
Debt to EBITDA
0.83x
0.50x
0.75x
—
—
—
—
—
Return on equity
12.18%
18.62%
7.76%
-3.69%
-9.05%
-18.36%
-24.90%
-23.77%
Return on assets
10.57%
16.03%
6.62%
-3.13%
-7.95%
-14.25%
-20.34%
-18.34%
Book value per share
28.57
27.33
23.19
19.37
17.10
8.35
8.49
5.80
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
INSP (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Golden Valley, MN
SEC filer status
Large accelerated filer
SEC CIK
1609550

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.